Recursion Pharmaceuticals
Salt Lake City
About Recursion Pharmaceuticals
Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate our programs. We are a biotechnology company scaling more like a technology company.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $50K – $100K
- Total funding: $865.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2024)
- Ticker: nasdaq:RXRX
- Website: recursion.com
- Phone: 385-269-0203
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Machine Learning, Pharmaceutical, Software
Social Profiles
Canonical: https://fsome.com/organization/recursion-pharmaceuticals-24206 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.